Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-04-11 07:48 |
Pharming announces publication of 2017 Annual Report and invitation to Annual G…
|
English | 145.8 KB | ||
| 2018-03-29 09:34 | English | 2.6 MB | |||
| 2018-03-15 07:45 |
Pharming enters the Euronext Amsterdam SmallCap-index (AScX)
|
English | 114.1 KB | ||
| 2018-03-12 08:31 |
Pharming announces issue of shares as majority of remaining warrants are exerci…
|
English | 496.3 KB | ||
| 2018-03-07 07:49 |
Pharming Group Report on Preliminary Financial Results for 2017
|
English | 212.3 KB | ||
| 2018-01-17 08:12 |
Pharming announces FDA Acceptance for Review of Supplemental Biologics License …
|
English | 101.8 KB | ||
| 2018-01-04 08:12 |
Pharming announces further conversion of its Ordinary Convertible Bonds
|
English | 98.8 KB | ||
| 2017-12-05 07:32 |
Pharming announces significant conversion of its Ordinary Convertible Bonds
|
English | 98.5 KB | ||
| 2017-11-27 08:42 |
Pharming Submits Supplemental Biologics License Application to FDA for RUCONEST…
|
English | 102.3 KB | ||
| 2017-10-26 07:28 |
Pharming Group reports financial results for the first nine months of 2017
|
English | 180.5 KB | ||
| 2017-10-02 08:56 |
Pharming announces positive data from paediatric clinical trial with RUCONEST®
|
English | 769.7 KB | ||
| 2017-09-26 08:08 |
Pharming Group N.V. and HAEi International Patient Organization announce partne…
|
English | 133.4 KB | ||
| 2017-09-11 09:31 |
Pharming announces conclusion of FDA End of Phase
|
English | 145.1 KB | ||
| 2017-08-10 07:03 |
Pharming announces cashless warrant exercises and conversions of its Ordinary B…
|
English | 446.3 KB | ||
| 2017-07-27 08:32 | English | 987.6 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
